Your Perfect Family Home Awaits: Spacious 5-Bedroom Gem in Fitzgibbon! Welcome to this exceptional 5-bedroom home, nestled in the heart of the highly coveted suburb of Fitzgibbon. Positioned ...

Looking for a block to build your dream family home? This 800m2 allotment is ready to settle and start your desired build! No uncertainty with long registration dates, this block is settled and ...

CORE Kidney, a patient support and advocacy group that helps patients with kidney disease navigate their complex journey, today announced its collaboration with Boehringer Ingelheim and Eli Lilly ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...

Through this experience and her work at Lilly, Crystal became more passionate about supporting caregivers as they support their loved ones living with the disease. As the number of people living ...

Eli Lilly has struck a $2.4 billion deal to buy Dice Therapeutics and its drug discovery and development platform for oral, small molecule therapies for immunological diseases. The big pharma is ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Dec. 2, 2024 — Scientists have discovered that pregnancy may trigger a natural immunity to boost protection against severe flu infection. Contrary to the common belief that pregnancy increases ...

In the three-year SURMOUNT-1 trial, tirzepatide curbed the risk of disease progression to Type 2 diabetes by 94% versus placebo in adult prediabetes patients who were obese or overweight ...